Compare HYLN & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HYLN | SLP |
|---|---|---|
| Founded | 2018 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | EDP Services |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 348.4M | 248.8M |
| IPO Year | 2019 | 1996 |
| Metric | HYLN | SLP |
|---|---|---|
| Price | $1.98 | $12.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $5.00 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 946.6K | 226.8K |
| Earning Date | 05-28-2026 | 04-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | $3,475,000.00 | ★ $59,577,000.00 |
| Revenue This Year | $32.29 | $2.64 |
| Revenue Next Year | $174.03 | $6.01 |
| P/E Ratio | ★ N/A | $414.67 |
| Revenue Growth | ★ 130.28 | 10.52 |
| 52 Week Low | $1.11 | $11.16 |
| 52 Week High | $2.56 | $36.43 |
| Indicator | HYLN | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 46.50 | 36.70 |
| Support Level | $1.86 | $11.16 |
| Resistance Level | $2.04 | $13.84 |
| Average True Range (ATR) | 0.13 | 0.53 |
| MACD | -0.00 | 0.26 |
| Stochastic Oscillator | 37.50 | 54.39 |
Hyliion Holdings Corp provides solutions that enable clean, flexible, and affordable electricity production. The Company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. It is initially targeting the commercial and waste management industries with a locally deployable generator that can offer prime power as well as energy arbitrage opportunities. In addition to stationary power solutions, it focuses on mobile applications, including vehicles and marine technologies.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.